Last reviewed · How we verify

NCT03927755: REASON-2

Timing For Single View Bedside Cardiac Ultrasound

Completed Last updated 16 April 2020
What this trial tests

trial testing Education in Echocardiography in 5,000 participants. Completed in 2 March 2020.

Timeline
1 June 2019
Primary endpoint
31 December 2019
2 March 2020

Quick facts

Lead sponsorUniversity of Massachusetts, Worcester
StatusCompleted
Study typeOBSERVATIONAL
Enrollment5,000
Start date1 June 2019
Primary completion31 December 2019
Estimated completion2 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Massachusetts, Worcester

Who can join

Eligibility, any sex, with Echocardiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to measure the hypothetical minimal amount of time it takes to perform a single view bedside trans-thoracic echo (TTE) comparing sub-xyphoid view and the parasternal long view. Physicians will be timed from initiation of imaging to completion of the recording of a single view of the heart. Images will be rated for quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Education

Trials testing the same drug.

Other recruiting trials for Echocardiography

Currently open trials in the same condition.

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing